{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:57:40Z","timestamp":1793653060155,"version":"4.5.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41401-025-01598-4","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T07:34:48Z","timestamp":1750404888000},"page":"2975-2988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation\u00a0in chronic kidney disease"],"prefix":"10.1038","volume":"46","author":[{"given":"Yan-ni","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-yan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"1598_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:473\u201385.","journal-title":"Nat Rev Nephrol"},{"key":"1598_CR2","doi-asserted-by":"publisher","first-page":"97214","DOI":"10.5527\/wjn.v13.i3.97214","volume":"13","author":"S Khandpur","year":"2024","unstructured":"Khandpur S, Mishra P, Mishra S, Tiwari S. Challenges in predictive modelling of chronic kidney disease: a narrative review. World J Nephrol. 2024;13:97214.","journal-title":"World J Nephrol"},{"key":"1598_CR3","doi-asserted-by":"publisher","first-page":"95410","DOI":"10.5527\/wjn.v13.i2.95410","volume":"13","author":"P Balakumar","year":"2024","unstructured":"Balakumar P. Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: the intricate connection with multifaceted mechanism. World J Nephrol. 2024;13:95410.","journal-title":"World J Nephrol"},{"key":"1598_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2023.07.014","volume":"207","author":"YN Wang","year":"2023","unstructured":"Wang YN, Miao H, Yu XY, Guo Y, Su W, Liu F, et al. Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy. Free Radic Biol Med. 2023;207:89\u2013106.","journal-title":"Free Radic Biol Med"},{"key":"1598_CR5","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/IMNA-D-23-00029","volume":"11","author":"D Liu","year":"2024","unstructured":"Liu D, Chen X, He W, Lu M, Li Q, Zhang S, et al. Update on the pathogenesis, diagnosis, and treatment of diabetic tubulopathy. Integr Med Nephrol Androl. 2024;11:e23\u201300029.","journal-title":"Integr Med Nephrol Androl"},{"key":"1598_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41392-024-01913-1","volume":"9","author":"H Miao","year":"2024","unstructured":"Miao H, Liu F, Wang YN, Yu XY, Zhuang S, Guo Y, et al. Targeting Lactobacillus johnsonii to reverse chronic kidney disease. Signal Transduct Target Ther. 2024;9:195.","journal-title":"Signal Transduct Target Ther"},{"key":"1598_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41401-022-00947-x","volume":"44","author":"YN Wang","year":"2023","unstructured":"Wang YN, Zhang ZH, Liu HJ, Guo ZY, Zou L, Zhang YM, et al. Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease. Acta Pharmacol Sin. 2023;44:393\u2013405.","journal-title":"Acta Pharmacol Sin"},{"key":"1598_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41581-023-00782-1","volume":"20","author":"R Correa-Rotter","year":"2024","unstructured":"Correa-Rotter R, Maple-Brown LJ, Sahay R, Tuttle KR. Ulasi II. New and emerging therapies for diabetic kidney disease. Nat Rev Nephrol. 2024;20:156\u201360.","journal-title":"Nat Rev Nephrol"},{"key":"1598_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","volume":"19","author":"V Rothhammer","year":"2019","unstructured":"Rothhammer V, Quintana FJ. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat Rev Immunol. 2019;19:184\u201397.","journal-title":"Nat Rev Immunol"},{"key":"1598_CR10","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1111\/bph.15062","volume":"177","author":"H Miao","year":"2020","unstructured":"Miao H, Cao G, Wu XQ, Chen YY, Chen DQ, Chen L, et al. Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation. Br J Pharmacol. 2020;177:3415\u201335.","journal-title":"Br J Pharmacol"},{"key":"1598_CR11","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1038\/s41401-022-00914-6","volume":"43","author":"G Cao","year":"2022","unstructured":"Cao G, Miao H, Wang YN, Chen DQ, Wu XQ, Chen L, et al. Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice. Acta Pharmacol Sin. 2022;43:2929\u201345.","journal-title":"Acta Pharmacol Sin"},{"key":"1598_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bph.16219","volume":"181","author":"H Miao","year":"2024","unstructured":"Miao H, Wang YN, Yu XY, Zou L, Guo Y, Su W, et al. Lactobacillus species ameliorate membranous nephropathy through inhibiting aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites. Br J Pharmacol. 2024;181:162\u201379.","journal-title":"Br J Pharmacol"},{"key":"1598_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bph.15705","volume":"179","author":"H Miao","year":"2022","unstructured":"Miao H, Wu XQ, Wang YN, Chen DQ, Chen L, Vaziri ND, et al. 1-Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway. Br J Pharmacol. 2022;179:103\u201324.","journal-title":"Br J Pharmacol"},{"key":"1598_CR14","doi-asserted-by":"publisher","first-page":"108314","DOI":"10.1016\/j.pharmthera.2022.108314","volume":"241","author":"Q Hu","year":"2023","unstructured":"Hu Q, Jiang L, Yan Q, Zeng J, Ma X, Zhao Y. A natural products solution to diabetic nephropathy therapy. Pharmacol Ther. 2023;241:108314.","journal-title":"Pharmacol Ther"},{"key":"1598_CR15","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41401-024-01404-7","volume":"46","author":"ZY Guo","year":"2024","unstructured":"Guo ZY, Wu X, Zhang SJ, Yang JH, Miao H, Zhao YY. Poria cocos: traditional uses, triterpenoid components and their renoprotective pharmacology. Acta Pharmacol Sin. 2024;46:836\u201351.","journal-title":"Acta Pharmacol Sin"},{"key":"1598_CR16","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00023","volume":"11","author":"Z Ruan","year":"2024","unstructured":"Ruan Z, Liu J, Liu W, Huang W. Qufeng tongluo decoction may alleviate podocyte injury induced by high glucose and hydrogen peroxide by regulating autophagy. Integr Med Nephrol Androl. 2024;11:e24\u201300023.","journal-title":"Integr Med Nephrol Androl"},{"key":"1598_CR17","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41401-023-01106-6","volume":"44","author":"TF Zou","year":"2023","unstructured":"Zou TF, Liu ZG, Cao PC, Zheng SH, Guo WT, Wang TX, et al. Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36\/fibrosis pathway. Acta Pharmacol Sin. 2023;44:2065\u201374.","journal-title":"Acta Pharmacol Sin"},{"key":"1598_CR18","doi-asserted-by":"publisher","first-page":"113296","DOI":"10.1016\/j.biopha.2022.113296","volume":"153","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Ren Q, Wu L. The pharmacokinetic property and pharmacological activity of acteoside: A review. Biomed Pharmacother. 2022;153:113296.","journal-title":"Biomed Pharmacother"},{"key":"1598_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.3014651","volume":"233","author":"Y Nishizuka","year":"1986","unstructured":"Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986;233:305\u201312.","journal-title":"Science"},{"key":"1598_CR20","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1021\/np50078a016","volume":"54","author":"JM Herbert","year":"1991","unstructured":"Herbert JM, Maffrand JP, Taoubi K, Augereau JM, Fouraste I, Gleye J. Verbascoside isolated from Lantana camara, an inhibitor of protein kinase C. J Nat Prod. 1991;54:1595\u2013600.","journal-title":"J Nat Prod"},{"key":"1598_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.redox.2018.02.015","volume":"16","author":"C Cheimonidi","year":"2018","unstructured":"Cheimonidi C, Samara P, Polychronopoulos P, Tsakiri EN, Nikou T, Myrianthopoulos V, et al. Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights. Redox Biol. 2018;16:169\u201378.","journal-title":"Redox Biol"},{"key":"1598_CR22","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/antiox10091445","volume":"10","author":"PF Hsieh","year":"2021","unstructured":"Hsieh PF, Yu CC, Chu PM, Hsieh PL. Verbascoside protects gingival cells against high glucose-induced oxidative stress via PKC\/HMGB1\/RAGE\/NF\u03baB pathway. Antioxidants (Basel). 2021;10:1445.","journal-title":"Antioxidants (Basel)"},{"key":"1598_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s10059-013-0021-1","volume":"35","author":"ES Seo","year":"2013","unstructured":"Seo ES, Oh BK, Pak JH, Yim SH, Gurunathan S, Kim YP, et al. Acteoside improves survival in cecal ligation and puncture-induced septic mice via blocking of high mobility group box 1 release. Mol Cells. 2013;35:348\u201354.","journal-title":"Mol Cells"},{"key":"1598_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12640-011-9292-5","volume":"21","author":"HQ Wang","year":"2012","unstructured":"Wang HQ, Xu YX, Zhu CQ. Upregulation of heme oxygenase-1 by acteoside through ERK and PI3 K\/Akt pathway confer neuroprotection against beta-amyloid-induced neurotoxicity. Neurotox Res. 2012;21:368\u201378.","journal-title":"Neurotox Res"},{"key":"1598_CR25","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/ijc.31378","volume":"143","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Yuan Y, Wu H, Xie Z, Wu Y, Song X, et al. Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma. Int J Cancer. 2018;143:980\u201391.","journal-title":"Int J Cancer"},{"key":"1598_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/0886022X.2018.1450762","volume":"40","author":"L Gan","year":"2018","unstructured":"Gan L, Li X, Zhu M, Chen C, Luo H, Zhou Q. Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy. Ren Fail. 2018;40:364\u201370.","journal-title":"Ren Fail"},{"key":"1598_CR27","doi-asserted-by":"publisher","first-page":"e14765","DOI":"10.7717\/peerj.14765","volume":"11","author":"Y Mao","year":"2023","unstructured":"Mao Y, Yu J, Da J, Yu F, Zha Y. Acteoside alleviates UUO-induced inflammation and fibrosis by regulating the HMGN1\/TLR4\/TREM1 signaling pathway. PeerJ. 2023;11:e14765.","journal-title":"PeerJ."},{"key":"1598_CR28","doi-asserted-by":"publisher","first-page":"115866","DOI":"10.1016\/j.jep.2022.115866","volume":"302","author":"W Gao","year":"2023","unstructured":"Gao W, Zhou Y, Li C, Liu T, Zhao H, Wang M, et al. Studies on the metabolism and mechanism of acteoside in treating chronic glomerulonephritis. J Ethnopharmacol. 2023;302:115866.","journal-title":"J Ethnopharmacol"},{"key":"1598_CR29","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1002\/ptr.7196","volume":"35","author":"Q Wang","year":"2021","unstructured":"Wang Q, Dai X, Xiang X, Xu Z, Su S, Wei D, et al. A natural product of acteoside ameliorate kidney injury in diabetes db\/db mice and HK-2 cells via regulating NADPH\/oxidase-TGF-\u03b2\/Smad signaling pathway. Phytother Res. 2021;35:5227\u201340.","journal-title":"Phytother Res"},{"key":"1598_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2306\/scienceasia1513-1874.2021.034","volume":"47","author":"YH Bai","year":"2021","unstructured":"Bai YH, Yang M, Feng ZJ, Zheng S. Acteoside ameliorates diabetic kidney disease via regulating the activation of the PPAR\u03b3\/\u03b2-catenin pathway. ScienceAsia. 2021;47:293\u2013302.","journal-title":"ScienceAsia."},{"key":"1598_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13765-022-00701-1","volume":"65","author":"CG Choi","year":"2022","unstructured":"Choi CG, Lee DJ, Chung N, Joo YH. Anti-obesity effects of isoacteoside on 3T3-L1 adipocytes. Appl Biol Chem. 2022;65:33.","journal-title":"Appl Biol Chem"},{"key":"1598_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3892\/mmr.2021.11926","volume":"23","author":"B Wang","year":"2021","unstructured":"Wang B, Li XH, Song Z, Li ML, Wu XW, Guo MX, et al. Isoacteoside attenuates acute kidney injury induced by severe acute pancreatitis. Mol Med Rep. 2021;23:287.","journal-title":"Mol Med Rep"},{"key":"1598_CR33","doi-asserted-by":"publisher","first-page":"154763","DOI":"10.1016\/j.phymed.2023.154763","volume":"114","author":"YN Wang","year":"2023","unstructured":"Wang YN, Miao H, Hua MR, Yang JZ, Pei M, Yu HX, et al. Moshen granule ameliorates membranous nephropathy by blocking intrarenal renin-angiotensin system signalling via the Wnt1\/\u03b2-catenin pathway. Phytomedicine. 2023;114:154763.","journal-title":"Phytomedicine."},{"key":"1598_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41401-023-01148-w","volume":"45","author":"H Miao","year":"2023","unstructured":"Miao H, Wang YN, Su W, Zou L, Zhuang SG, Yu XY, et al. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway. Acta Pharmacol Sin. 2023;45:137\u201349.","journal-title":"Acta Pharmacol Sin"},{"key":"1598_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41581-023-00775-0","volume":"20","author":"S Kishi","year":"2024","unstructured":"Kishi S, Nagasu H, Kidokoro K, Kashihara N. Oxidative stress and the role of redox signalling in chronic kidney disease. Nat Rev Nephrol. 2024;20:101\u201319.","journal-title":"Nat Rev Nephrol"},{"key":"1598_CR36","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389:1238\u201352.","journal-title":"Lancet."},{"key":"1598_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.37349\/emed.2023.00141","volume":"4","author":"I Rashid","year":"2023","unstructured":"Rashid I, Tiwari P, D\u2019Cruz S, Jaswal S. Prognostic importance of neutrophil-lymphocyte ratio in non-dialysis chronic kidney disease patients\u2014a hospital-based prospective cohort. Explor Med. 2023;4:299\u2013313.","journal-title":"Explor Med"},{"key":"1598_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398:786\u2013802.","journal-title":"Lancet."},{"key":"1598_CR39","doi-asserted-by":"publisher","first-page":"90402","DOI":"10.5527\/wjn.v13.i1.90402","volume":"13","author":"M Ndongo","year":"2024","unstructured":"Ndongo M, Nehemie LM, Coundoul B, Diouara AAM, Seck SM. Prevalence and outcomes of polycystic kidney disease in African populations: a systematic review. World J Nephrol. 2024;13:90402.","journal-title":"World J Nephrol"},{"key":"1598_CR40","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41573-023-00774-7","volume":"22","author":"MW Mullowney","year":"2023","unstructured":"Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, et al. Artificial intelligence for natural product drug discovery. Nat Rev Drug Discov. 2023;22:895\u2013916.","journal-title":"Nat Rev Drug Discov"},{"key":"1598_CR41","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41401-023-01051-4","volume":"44","author":"YF Shao","year":"2023","unstructured":"Shao YF, Tang BB, Ding YH, Fang CY, Hong L, Shao CX, et al. Kaempferide ameliorates cisplatin-induced nephrotoxicity via inhibiting oxidative stress and inducing autophagy. Acta Pharmacol Sin. 2023;44:1442\u201354.","journal-title":"Acta Pharmacol Sin"},{"key":"1598_CR42","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1097\/IMNA-D-22-00016","volume":"11","author":"X Zhong","year":"2024","unstructured":"Zhong X, Jia J, Tan R, Wang L. Hederagenin improves adriamycin-induced nephropathy by inhibiting the JAK\/STAT signaling pathway. Integr Med Nephrol Androl. 2024;11:e22\u201300016.","journal-title":"Integr Med Nephrol Androl"},{"key":"1598_CR43","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41401-023-01156-w","volume":"45","author":"B Wang","year":"2024","unstructured":"Wang B, Yang LN, Yang LT, Liang Y, Guo F, Fu P, et al. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis. Acta Pharmacol Sin. 2024;45:150\u201365.","journal-title":"Acta Pharmacol Sin"},{"key":"1598_CR44","doi-asserted-by":"publisher","first-page":"95262","DOI":"10.5527\/wjn.v13.i3.95262","volume":"13","author":"A Vagopoulou","year":"2024","unstructured":"Vagopoulou A, Theofilis P, Karasavvidou D, Haddad N, Makridis D, Tzimikas S, et al. Pilot study on the effect of flavonoids on arterial stiffness and oxidative stress in chronic kidney disease. World J Nephrol. 2024;13:95262.","journal-title":"World J Nephrol"},{"key":"1598_CR45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.37349\/emed.2024.00230","volume":"5","author":"W Du","year":"2024","unstructured":"Du W, Di Martino L, Li J. Natural polysaccharides-based postbiotics and their potential applications. Explor Med. 2024;5:444\u201358.","journal-title":"Explor Med"},{"key":"1598_CR46","doi-asserted-by":"publisher","first-page":"104131","DOI":"10.1016\/j.bse.2020.104131","volume":"92","author":"MJ Uddin","year":"2020","unstructured":"Uddin MJ, \u00c7i\u00e7ek SS, Willer J, Shulha O, Abdalla MA, S\u00f6nnichsen F, et al. Phenylpropanoid and flavonoid glycosides from the leaves of Clerodendrum infortunatum (Lamiaceae). Biochem Syst Ecol. 2020;92:104131.","journal-title":"Biochem Syst Ecol"},{"key":"1598_CR47","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41392-024-02042-5","volume":"9","author":"X Jiang","year":"2024","unstructured":"Jiang X, Wang J, Lin L, Du L, Ding Y, Zheng F, et al. Macrophages promote pre-metastatic niche formation of breast cancer through aryl hydrocarbon receptor activity. Signal Transduct Target Ther. 2024;9:352.","journal-title":"Signal Transduct Target Ther"},{"key":"1598_CR48","doi-asserted-by":"publisher","first-page":"115626","DOI":"10.1016\/j.bcp.2023.115626","volume":"213","author":"L Sl\u00e1dekov\u00e1","year":"2023","unstructured":"Sl\u00e1dekov\u00e1 L, Mani S, Dvo\u0159\u00e1k Z. Ligands and agonists of the aryl hydrocarbon receptor AhR: Facts and myths. Biochem Pharmacol. 2023;213:115626.","journal-title":"Biochem Pharmacol"},{"key":"1598_CR49","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/j.arr.2023.101928","volume":"87","author":"A Salminen","year":"2023","unstructured":"Salminen A. Aryl hydrocarbon receptor (AhR) impairs circadian regulation: Impact on the aging process. Ageing Res Rev. 2023;87:101928.","journal-title":"Ageing Res Rev"},{"key":"1598_CR50","doi-asserted-by":"publisher","first-page":"102622","DOI":"10.1016\/j.redox.2023.102622","volume":"61","author":"CJG Pinto","year":"2023","unstructured":"Pinto CJG, \u00c1vila-G\u00e1lvez M, Lian Y, Moura-Alves P, Nunes Dos Santos C. Targeting the aryl hydrocarbon receptor by gut phenolic metabolites: a strategy towards gut inflammation. Redox Biol. 2023;61:102622.","journal-title":"Redox Biol"},{"key":"1598_CR51","doi-asserted-by":"publisher","first-page":"101530","DOI":"10.1016\/j.redox.2020.101530","volume":"34","author":"CFA Vogel","year":"2020","unstructured":"Vogel CFA. Van Winkle LS, Esser C, Haarmann-Stemmann T. The aryl hydrocarbon receptor as a target of environmental stressors - Implications for pollution mediated stress and inflammatory responses. Redox Biol. 2020;34:101530.","journal-title":"Redox Biol"},{"key":"1598_CR52","doi-asserted-by":"publisher","first-page":"1859812","DOI":"10.1080\/19490976.2020.1859812","volume":"12","author":"F Dong","year":"2020","unstructured":"Dong F, Perdew GH. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay. Gut Microbes. 2020;12:1859812.","journal-title":"Gut Microbes"},{"key":"1598_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2054-5","volume":"17","author":"H Zhao","year":"2019","unstructured":"Zhao H, Chen L, Yang T, Feng YL, Vaziri ND, Liu BL, et al. Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma. J Transl Med. 2019;17:302.","journal-title":"J Transl Med"},{"key":"1598_CR54","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bph.16229","volume":"181","author":"Y Ying","year":"2024","unstructured":"Ying Y, Song LY, Pang WL, Zhang SQ, Yu JZ, Liang PT, et al. Astragalus polysaccharide protects experimental colitis through an aryl hydrocarbon receptor-dependent autophagy mechanism. Br J Pharmacol. 2024;181:681\u201397.","journal-title":"Br J Pharmacol"},{"key":"1598_CR55","doi-asserted-by":"publisher","first-page":"116244","DOI":"10.1016\/j.jep.2023.116244","volume":"308","author":"Y Mo","year":"2023","unstructured":"Mo Y, Hu D, Yu W, Ji C, Li Y, Liu X, et al. Astragaloside IV attenuates indoxyl sulfate-induced injury of renal tubular epithelial cells by inhibiting the aryl hydrocarbon receptor pathway. J Ethnopharmacol. 2023;308:116244.","journal-title":"J Ethnopharmacol"},{"key":"1598_CR56","doi-asserted-by":"publisher","first-page":"12853","DOI":"10.1021\/acs.jafc.1c05250","volume":"69","author":"MZ Li","year":"2021","unstructured":"Li MZ, Zhao Y, Wang HR, Talukder M, Li JL. Lycopene preventing DEHP-induced renal cell damage is targeted by aryl hydrocarbon receptor. J Agric Food Chem. 2021;69:12853\u201361.","journal-title":"J Agric Food Chem"},{"key":"1598_CR57","doi-asserted-by":"publisher","first-page":"922707","DOI":"10.3389\/fphar.2022.922707","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Deng R, Chen Y, Huang S, Lu J, Zheng L, et al. Jian-Pi-Yi-Shen formula improves adenine-induced chronic kidney disease via regulating tryptophan metabolism and aryl hydrocarbon receptor signaling. Front Pharmacol. 2022;13:922707.","journal-title":"Front Pharmacol"},{"key":"1598_CR58","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12906-021-03376-1","volume":"21","author":"Y Mo","year":"2021","unstructured":"Mo Y, Jie X, Wang L, Ji C, Gu Y, Lu Z, et al. Bupi Yishen formula attenuates kidney injury in 5\/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway. BMC Complement Med Ther. 2021;21:207.","journal-title":"BMC Complement Med Ther"},{"key":"1598_CR59","doi-asserted-by":"publisher","first-page":"1335094","DOI":"10.3389\/fphar.2023.1335094","volume":"14","author":"N Ren","year":"2023","unstructured":"Ren N, Wang WF, Zou L, Zhao YL, Miao H, Zhao YY. The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis. Front Pharmacol. 2023;14:1335094.","journal-title":"Front Pharmacol"},{"key":"1598_CR60","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1002\/ptr.8324","volume":"38","author":"YN Wang","year":"2024","unstructured":"Wang YN, Li XJ, Wang WF, Zou L, Miao H, Zhao YY. Geniposidic acid attenuates chronic tubulointerstitial nephropathy through regulation of the NF\u2010\u03baB\/Nrf2 pathway via aryl hydrocarbon receptor signaling. Phytother Res. 2024;38:5441\u201357.","journal-title":"Phytother Res"},{"key":"1598_CR61","doi-asserted-by":"publisher","first-page":"1386604","DOI":"10.3389\/fphar.2024.1386604","volume":"15","author":"XJ Li","year":"2024","unstructured":"Li XJ, Wang YN, Wang WF, Nie X, Miao H, Zhao YY. Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation. Front Pharmacol. 2024;15:1386604.","journal-title":"Front Pharmacol"},{"key":"1598_CR62","doi-asserted-by":"publisher","first-page":"312","DOI":"10.37349\/emed.2024.00222","volume":"5","author":"MJ Naim","year":"2024","unstructured":"Naim MJ. A review on mushrooms as a versatile therapeutic agent with emphasis on its bioactive constituents for anticancer and antioxidant potential. Explor Med. 2024;5:312\u201330.","journal-title":"Explor Med"},{"key":"1598_CR63","doi-asserted-by":"publisher","first-page":"1365802","DOI":"10.3389\/fphar.2024.1365802","volume":"15","author":"XJ Li","year":"2024","unstructured":"Li XJ, Suo P, Wang YN, Zou L, Nie XL, Zhao YY, et al. Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition. Front Pharmacol. 2024;15:1365802.","journal-title":"Front Pharmacol"},{"key":"1598_CR64","first-page":"1934578X2211348","volume":"17","author":"YC Jiang","year":"2022","unstructured":"Jiang YC, Lin X, Mao Y, Zhao JQ, Zhang GH, Yu JL, et al. Acteoside alleviates renal fibrosis by inhibiting \u03b2-catenin\/CTGF signaling pathway in UUO rats. Nat Prod Commun. 2022;17:1934578X2211348.","journal-title":"Nat Prod Commun"},{"key":"1598_CR65","doi-asserted-by":"publisher","first-page":"1721727X2211183","DOI":"10.1177\/1721727X221118348","volume":"20","author":"Y Xie","year":"2022","unstructured":"Xie Y, Lin X, Yuan J, Dong R, Yu JL, Zha Y. Effects of acteoside on the expressions of MCP-1 and TGF-\u03b21 in the diabetic nephropathy mice. Eur J Inflamm. 2022;20:1721727X221118348.","journal-title":"Eur J Inflamm"},{"key":"1598_CR66","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3390\/ijms17081327","volume":"17","author":"X Zhang","year":"2016","unstructured":"Zhang X, He H, Liang D, Jiang Y, Liang W, Chi ZH, et al. Protective effects of berberine on renal injury in streptozotocin (STZ)-induced diabetic mice. Int J Mol Sci. 2016;17:1327.","journal-title":"Int J Mol Sci"},{"key":"1598_CR67","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18:379\u2013401.","journal-title":"Nat Rev Drug Discov"},{"key":"1598_CR68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L V\u00e9csei","year":"2013","unstructured":"V\u00e9csei L, Szal\u00e1rdy L, F\u00fcl\u00f6p F, Toldi J. Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov. 2013;12:64\u201382.","journal-title":"Nat Rev Drug Discov"},{"key":"1598_CR69","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/IMNA-D-23-00024","volume":"11","author":"H Zhao","year":"2024","unstructured":"Zhao H, Zhao T, Li P. Gut microbiota-derived metabolites: a new perspective of traditional Chinese medicine against diabetic kidney disease. Integr Med Nephrol Androl. 2024;11:e23\u201300024.","journal-title":"Integr Med Nephrol Androl"},{"key":"1598_CR70","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone TW, Darlington LG. Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov. 2002;1:609\u201320.","journal-title":"Nat Rev Drug Discov"},{"key":"1598_CR71","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00018-024-05532-5","volume":"81","author":"XJ Li","year":"2024","unstructured":"Li XJ, Shan QY, Wu X, Miao H, Zhao YY. Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis. Cell Mol Life Sci. 2024;81:480.","journal-title":"Cell Mol Life Sci"},{"key":"1598_CR72","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1007\/s11255-022-03137-0","volume":"54","author":"V Cernaro","year":"2022","unstructured":"Cernaro V, Calabrese V, Loddo S, Corsaro R, Macaione V, Ferlazzo VT, et al. Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients. Int Urol Nephrol. 2022;54:2355\u201364.","journal-title":"Int Urol Nephrol"},{"key":"1598_CR73","doi-asserted-by":"publisher","first-page":"114917","DOI":"10.1016\/j.fct.2024.114917","volume":"192","author":"S Nayak","year":"2024","unstructured":"Nayak S, Boopathi S, Chandrasekar M, Panda SP, Manikandan K, Chitra V, et al. Indole-3-acetic acid exposure leads to cardiovascular inflammation and fibrosis in chronic kidney disease rat model. Food Chem Toxicol. 2024;192:114917.","journal-title":"Food Chem Toxicol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01598-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:02:36Z","timestamp":1761292956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01598-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01598-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}